Some studies have shown that PLXND1 was overexpressed in tumor cells and promoted tumor development and progression in several cancers, including colon cancers (11), melanoma (30), pancreatic cancer (31), and ovarian cancer (12). Here, PLXND1 is linked to neoplasm.